Considerations For Clinical Studies In Heavy Menstrual Bleeding
Heavy menstrual bleeding (HMB) is one of the most common gynecologic disorders among women of reproductive age, accounting for up to one-third of all gynecologic office visits HMB refers to bleeding associated with regular ovulatory cycles and involves blood loss greater than 80 ml per month. It is a subcategory of abnormal uterine bleeding (AUB), a broad term describing menstrual cycle irregularities involving frequency, regularity, duration, or volume of flow. The condition can adversely impact quality of life and can result in anemia.
In this blog post, explore key operational and methodological considerations for HMB clinical studies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.